Aclarion, Inc. cotiza a 2.24 USD y tiene una capitalización bursátil de $6M. En los últimos 12 meses ha facturado $83769 con un margen de flujo de caja libre del -9488.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup …
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-1.12 | $-1.34 | $-4.52 | $-2.93 |
| Estimado | $-1.05 | $-1.55 | $-3.60 | $-2.64 |
| Sorpresa | -6.7% | +13.5% | -25.6% | -11.0% |
| Métrica | ACON | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 9.0% | 57.0% | -48.0% |
| Operating Margin | -9312.5% | -38.6% | -9273.9% |
| Net Margin | -9551.9% | -33.6% | -9518.3% |
| FCF Margin | -9488.6% | -13.9% | -9474.8% |
| ROE | -56.4% | -40.4% | -16.0% |
| ROA | -52.9% | -32.0% | -20.9% |
| Current Ratio | 14.81 | 2.84 | +11.97 |
| Debt / Equity | — | 0.28 | — |